Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Phlebotomy × Myeloid × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1 Myeloproliferative Disorders 1

Interventions

nilotinib 12 Imatinib Mesylate 10 Dasatinib 3 fludarabine 2 bosutinib 2 Cyclophosphamide 2 Busulfan 2 zanubrutinib 1 trametinib 1 ruxolitinib 1 posaconazole 1 fludarabine phosphate 1 eltrombopag 1 dabrafenib 1 asciminib 1 Thiotepa 1 Rituximab 1 Radiotherapy 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Interferons 1 Idarubicin 1 Growth Hormone 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Decitabine 1 Cytarabine 1 Cholecalciferol 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06290765 2025-07-31

PV

PharmaEssentia

Phase 4 Not yet recruiting

Myeloproliferative Disorders, Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡